Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 2/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31362022 | 1.00 | CYP2C19 (0.34) | CYP2C19CYP2D6ALOX15MEN1KMT2A | |
| SCHEMBL30139623 | 0.84 | ALOX15 (0.31) | ALOX15MEN1KMT2A | |
| SCHEMBL27008262 | 0.82 | CYP2D6 (0.36) | CYP2C19CYP2D6ALOX15 | |
| SCHEMBL31362044 | 0.81 | TSHR (0.35) | CYP2C19MEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL31362045 | 0.81 | TSHR (0.35) | CYP2C19MEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL5052677 | 0.79 | HCAR2 (0.48) | CYP2C19MEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL11809485 | 0.79 | TSHR (0.39) | CYP2C19MEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL7771261 | 0.79 | HCAR2 (0.48) | CYP2C19MEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL7770947 | 0.79 | HCAR2 (0.48) | CYP2C19MEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL11809477 | 0.79 | TSHR (0.39) | CYP2C19MEN1KMT2AKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4674894-A2 | COPOLYMERS OF N-VINYLPYRROLIDONE WITH FUNCTIONALIZED MALEIC ACID MOIETIES | Hemoteq AG (DE) | 2026-01-07 | — | — | EP | disclosed |
| EP-4663688-A2 | CROSSLINKERS | Hemoteq AG (DE) | 2025-12-17 | — | — | EP | disclosed |
| EP-4584243-B1 | CROSSLINKERS | HEMOTEQ AG (DE) | 2025-11-05 | — | — | EP | disclosed |
| EP-4584245-A1 | COPOLYMERS OF N-VINYLPYRROLIDONE WITH FUNCTIONALIZED MALEIC ACID MOIETIES | Hemoteq AG (DE) | 2025-07-16 | — | — | EP | disclosed |
| EP-4584244-A1 | COPOLYMERS OF N-VINYLPYRROLIDONE WITH FUNCTIONALIZED MALEIC ACID MOIETIES | Hemoteq AG (DE) | 2025-07-16 | — | — | EP | disclosed |
| EP-4584243-A1 | CROSSLINKERS | Hemoteq AG (DE) | 2025-07-16 | — | — | EP | disclosed |
| WO-2025056815-A1 | COPOLYMERS OF N-VINYLPYRROLIDONE WITH FUNCTIONALIZED MALEIC ACID MOIETIES | HEMOTEQ AG (DE) | 2025-03-20 | — | — | WO | disclosed |
| WO-2025056814-A1 | CROSSLINKERS | HEMOTEQ AG (DE) | 2025-03-20 | — | — | WO | disclosed |
| WO-2025056813-A1 | COPOLYMERS OF N-VINYLPYRROLIDONE WITH FUNCTIONALIZED MALEIC ACID MOIETIES | HEMOTEQ AG (DE) | 2025-03-20 | — | — | WO | disclosed |
| EP-4524128-A1 | BENZOPHENONE CROSSLINKERS | Hemoteq AG (DE) | 2025-03-19 | — | — | EP | disclosed |